Efficacy and Safety of C2L-OCT-01 PR in Acromegalic Patients
Clinical trial NCT00616551 · COMPLETED
Trial details
- NCT number
- NCT00616551
- Sponsor
- Ambrilia Biopharma, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2008-02-01
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.